NeoTract | Teleflex
4473 Willow Rd, Suite 100
Tel: (925) 401-0700
About NeoTract | Teleflex
NeoTract is a medical device company featuring a revolutionary technology called The UroLift® System. The UroLift® System treats BPH (benign prostatic hyperplasia) by lifting and holding enlarged prostate tissue so it no longer blocks the urethra. It is the only BPH procedure that does not require cutting, heating, or removal of the prostate tissue. Over 60,000 patients have been treated with UroLift®, and we are currently seeking exceptional talent to enable us to treat even more patients.
Stock Symbol: TFX
NeoTract president, Dave Amerson, shares his vision for the company.
3 articles with NeoTract | Teleflex
Liam Kelly, President and CEO, Teleflex Incorporated, is scheduled to speak at the Credit Suisse 27th Annual Healthcare Conference.
NeoTract today announced the company received the Phoenix 2018 Emerging Growth Company Award at the 25th Annual Phoenix Medical Device and Diagnostic Conference.
NeoTract Announces Data from New Real-World Study Demonstrating Excellent Results for UroLift® System Treatment for Enlarged Prostate
Early Results Reported to Be Better Than Pivotal Trial Data at Experienced Center